Catharine L. Smith

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma”.

Defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma

Translational Oncology(2023)10.1016/j.tranon.2023.101779

N/A

0DataRank · unranked

8 citations

Ana A. Tula-Sanchez, Hailey M. Steenhoek, Anvi Bhakta, Taylor Wingfield, Matthew J. Huntley +5 more

Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression.

PubMed(2024)10.14670/hh-18-644

N/A

0DataRank · unranked

2 citations

Margaret E. Tome, Dean Billheimer, Catherine Spier, Catharine L. Smith, Daniel O. Persky +2 more